K161208 is an FDA 510(k) clearance for the CROSSER CTO Recanalization Catheter. Classified as Catheter For Crossing Total Occlusions (product code PDU), Class II - Special Controls.
Submitted by Bard Peripheral Vacular, Inc. (Tempe, US). The FDA issued a Cleared decision on May 24, 2016 after a review of 26 days - a notably fast clearance cycle.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.